NEWSCORE[Pharmaceuticals]
COPYRIGHT ©2026
ALL RIGHTS RESERVED.
AI Native Cyber Intelligence
NEWSCORE.FR
NewsCore enables you to monitor your healthcare ecosystem:
Dynamic mapping of labs, hospitals, startups and institutions
Detection of new treatments and biotech players
Monitoring of market evolutions by therapeutic area
Partnership
Major hospital-lab partnership announced
30/01/2026
91%
New entrant
Chinese biotech entering European market
29/01/2026
88%
Industry
Restructuring of major French laboratory
28/01/2026
85%
Écosystème Santé
SanofiLaboratoire
AP-HPHôpital
DoctolibStartup
+847 acteurs mappés
DIGITAL HEALTH
Français
Phase III clinical trial: new oncology treatment based on AI diagnostics
28/01/2026
health innovation94%
IA SantéPhase III
Type
Clinical trial
Segment
Oncology / AI
NewsCore enables you to track digital health and innovation:
Monitoring of health data platforms, AI and telemedicine initiatives
Detection of clinical trials, patents and scientific publications
Identification of weak signals and disruptive medical technologies
NewsCore enables you to analyze regulation and health economics:
Tracking of drug pricing, reimbursement and access mechanisms
Monitoring of healthcare financing laws and hospital tariffs
Detection of regulatory changes impacting prescriptions and funding
Reimbursement
New biosimilar reimbursement rules
30/01/2026
93%
Pricing
Tense drug pricing negotiations
29/01/2026
90%
Funding
Hospital financing reform announced
28/01/2026
87%
ÉCONOMIE SANTÉ
Urgent
Q4 2025 hospital tariff revision: major impact on 12 therapeutic areas
25/01/2026
health regulation89%
PricingHAS
Type
Regulatory alert
Impact
Hospital tariffs
DRUG PORTFOLIO
Français
Imminent launch of a competing biosimilar in the oncology segment
22/01/2026
pharma competition92%
BiosimilairePipeline
Type
Product launch
Segment
Oncology
NewsCore enables you to monitor competition and drug portfolios:
Tracking of competing drugs by therapeutic area
Monitoring of R&D pipelines and product launches
Detection of partnerships and licensing agreements
NewsCore enables you to anticipate reputational and social risks:
Monitoring of adverse effects and safety controversies
Tracking of hospital cyber risks and system vulnerabilities
Detection of ESG, ethics and supply chain risk signals
Pharmacovigilance
Alert on treatment side effects
30/01/2026
95%
Cyber
Cyberattack on major hospital group
29/01/2026
92%
ESG
ESG controversy over lab practices
28/01/2026
86%
PHARMACOVIGILANCE
Alerte
Pharmacovigilance alert: adverse effects reported on 3 molecules under surveillance
20/01/2026
reputation risk96%
VigilanceANSM
Type
Risk signal
Level
Enhanced surveillance
Discover NewsCore for your industry
A personalized demonstration tailored to your business challenges.